Screener
Integra LifeSciences IART Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000917520-26-000058
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| INVESTING ACTIVITIES: | ||
| Purchases of property and equipment | (27,155) | (49,066) |
| Purchases of short-term investments | (30,976) | (8,502) |
| Net cash used in investing activities | (58,131) | (57,568) |
| FINANCING ACTIVITIES: | ||
| Proceeds from borrowings of long-term indebtedness | 75,900 | 67,300 |
| Payments on debt | (60,475) | (31,131) |
| Payment of debt issuance costs | (275) | (3,855) |
Item 1. Financial Statements
FAQ
- What is Integra LifeSciences's investing cash flow?
- Integra LifeSciences (IART) reported investing cash flow of -$43.28M in Q2 2026.
- How has Integra LifeSciences's investing cash flow changed year-over-year?
- Integra LifeSciences's investing cash flow decreased by 99.9% year-over-year, from -$21.65M to -$43.28M.
- What is the long-term trend for Integra LifeSciences's investing cash flow?
- Over 3 years (2021 to 2025), Integra LifeSciences's investing cash flow has grown at a -12.5% compound annual growth rate (CAGR), from -$161.44M to -$108.06M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Integra LifeSciences's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude